✦ LIBER ✦

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial

✍ Scribed by Ardizzoni, A.; Tiseo, M.; Boni, L.; Vincent, A. D.; Passalacqua, R.; Buti, S.; Amoroso, D.; Camerini, A.; Labianca, R.; Genestreti, G.; Boni, C.; Ciuffreda, L.; Di Costanzo, F.; de Marinis, F.; Crino, L.; Santo, A.; Pazzola, A.; Barbieri, F.; Zilembo, N.; Colantonio, I.; Tibaldi, C.; Mattioli, R.; Cafferata, M. A.; Camisa, R.; Smit, E. F.

Book ID: 118174864
Publisher: American Society of Clinical Oncology
Year: 2012
Tongue: English
Weight: 200 KB
Volume: 30
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2012.43.6758

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of First-line Bevacizum

A Phase II Trial of First-line Bevacizumab in Combination With Pemetrexed and Carboplatin in Advanced Nonsquamous Non–Small-Cell Lung Cancer: Preliminary Results

✍ Z. Skaff; A. Hageboutros; K. Krieger; S. Coakley; R. Somer; J. Stevenson 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 43 KB

O-271 Phase II randomized study of pemet

O-271 Phase II randomized study of pemetrexed plus carboplatin or oxaliplatin, as front-line chemotherapy in patients with locally advanced or metastatic non-small-cell lung cancer

✍ Scagliotti, G.V.; Kortsik, C.; Manegold, C.; Dark, G.; Crino, L.; O'Brien, M.E.R 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 185 KB

A Randomized Phase II Study of Pemetrexe

A Randomized Phase II Study of Pemetrexed or RAD001 as Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients: Treatment Rationale and Protocol Dynamics

✍ Cesare Gridelli; Antonio Rossi; Floriana Morgillo; Maria Anna Bareschino; Paolo 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 104 KB

P-488 Phase II randomized trial of singl

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

✍ Gridelli, C.; Reck, M.; Gregorc, V.; Migliorino, M.; Muller, T.; Manegold, C.; F 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

A phase II, randomized, multicenter stud

A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer

✍ Christos Chouaid; Faith Nathan; Kristine Pemberton; Thomas Morris 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 244 KB

Gefitinib versus pemetrexed as second-li

Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01) : An open-label, phase 3 trial

✍ Jong-Mu Sun; Ki Hyeong Lee; Sang-we Kim; Dae Ho Lee; Young Joo Min; Hwan Jung Yu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB